We assessed the antineoplastic effect and adverse reactions of paclitaxel monotherapy with paclitaxel 210 mg/m(2) given every 3 weeks by 3-h infusion on patients with endometrial cancer given as a 3-h infusion.
Department of Gynecology, Cancer Institute Hospital, Japanese Foundation of Cancer Research, 1-37-1 Kami-Ikebukuro, Toshimaku, Tokyo 170-8455, Japan. yhirai@jfcr.or.jp
